11 – 16 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2015
-
Mark
The growth hormone receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population.
(
- Contribution to journal › Article
-
Mark
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
(
- Contribution to journal › Article
- 2014
-
Mark
Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
(
- Contribution to journal › Article
- 2013
-
Mark
Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy.
(
- Contribution to journal › Article
- 2007
-
Mark
Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone
(
- Contribution to journal › Article
-
Mark
Fracture incidence in GH-deficient patients on complete hormone replacement including GH
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »